Pradeep Natarajan, MD, MMSc

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    TenSixteen
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Tourmaline Bio
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Bolt
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Candela
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Mercury
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    MyOme
    Topic:
    genetic testing
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Parameter Health
    Topic:
    CVD precision medicine
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Preciseli
    Topic:
    genetic testing
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    TenSixteen Bio
    Topic:
    CVD drug development
    Date added:
    12/05/2025
    Date updated:
    12/05/2025
    Relationship end date:
    12/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Intellectual Property Other
    Ineligible company:
    Recora
    Topic:
    cardiac rehabilitation
    Date added:
    12/05/2025
    Date updated:
    12/05/2025

Pages

Return to 2025 Inova Fairfax Medicine Grand Rounds 12/09/2025